Literature DB >> 31369800

Unconventional ST2- and CD127-negative lung ILC2 populations are induced by the fungal allergen Alternaria alternata.

Kellen J Cavagnero1, Jana H Badrani1, Luay H Naji1, Michael B Amadeo1, Veranca S Shah1, Suzanna Gasparian1, Alexa Pham1, Alice W Wang2, Grégory Seumois2, Michael Croft3, David H Broide1, Taylor A Doherty4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31369800      PMCID: PMC6938690          DOI: 10.1016/j.jaci.2019.07.018

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Alternaria induces STAT6-dependent acute airway eosinophilia and epithelial FIZZ1 expression that promotes airway fibrosis and epithelial thickness.

Authors:  Taylor A Doherty; Naseem Khorram; Kotaro Sugimoto; Dean Sheppard; Peter Rosenthal; Jae Youn Cho; Alexa Pham; Marina Miller; Michael Croft; David H Broide
Journal:  J Immunol       Date:  2012-02-10       Impact factor: 5.422

2.  Alternaria-induced asthma.

Authors:  Robert K Bush; Jay J Prochnau
Journal:  J Allergy Clin Immunol       Date:  2004-02       Impact factor: 10.793

3.  STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria.

Authors:  Taylor A Doherty; Naseem Khorram; Jinny E Chang; Hee-Kyoo Kim; Peter Rosenthal; Michael Croft; David H Broide
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-03       Impact factor: 5.464

4.  IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity.

Authors:  Yoichiro Ohne; Jonathan S Silver; LuAnn Thompson-Snipes; Magalie A Collet; Jean Philippe Blanck; Brandi L Cantarel; Alan M Copenhaver; Alison A Humbles; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2016-04-25       Impact factor: 25.606

5.  Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs.

Authors:  Jonathan S Silver; Jennifer Kearley; Alan M Copenhaver; Caroline Sanden; Michiko Mori; Li Yu; Gretchen Harms Pritchard; Aaron A Berlin; Christopher A Hunter; Russell Bowler; Jonas S Erjefalt; Roland Kolbeck; Alison A Humbles
Journal:  Nat Immunol       Date:  2016-04-25       Impact factor: 25.606

6.  IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs.

Authors:  Kathleen R Bartemes; Koji Iijima; Takao Kobayashi; Gail M Kephart; Andrew N McKenzie; Hirohito Kita
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

Review 7.  Emerging concepts and future challenges in innate lymphoid cell biology.

Authors:  Elia D Tait Wojno; David Artis
Journal:  J Exp Med       Date:  2016-10-10       Impact factor: 14.307

8.  Interleukin 33 Selectively Augments Rhinovirus-Induced Type 2 Immune Responses in Asthmatic but not Healthy People.

Authors:  Lisa M Jurak; Yang Xi; Megan Landgraf; Melanie L Carroll; Liisa Murray; John W Upham
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561

Review 9.  Airway innate lymphoid cells in the induction and regulation of allergy.

Authors:  Taylor A Doherty; David H Broide
Journal:  Allergol Int       Date:  2018-11-23       Impact factor: 5.836

  9 in total
  10 in total

1.  Optimal identification of human conventional and nonconventional (CRTH2-IL7Rα-) ILC2s using additional surface markers.

Authors:  Sucai Liu; Kapil Sirohi; Mukesh Verma; Jerome McKay; Lidia Michalec; Anand Sripada; Tomas Danhorn; Donald Rollins; James Good; Magdalena M Gorska; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2020-02-04       Impact factor: 10.793

Review 2.  Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma.

Authors:  Mukesh Verma; Divya Verma; Rafeul Alam
Journal:  Curr Opin Allergy Clin Immunol       Date:  2022-02-01

3.  Detection, Isolation, and Functional Studies of Mouse Pulmonary Group 2 Innate Lymphoid Cells.

Authors:  Allyssa N Strohm; Taylor A Doherty
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Roles of innate lymphoid cells (ILCs) in allergic diseases: The 10-year anniversary for ILC2s.

Authors:  Kathleen R Bartemes; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2021-05       Impact factor: 10.793

Review 5.  Immune Checkpoints and Innate Lymphoid Cells-New Avenues for Cancer Immunotherapy.

Authors:  Nicolas Jacquelot; Maryam Ghaedi; Kathrin Warner; Douglas C Chung; Sarah Q Crome; Pamela S Ohashi
Journal:  Cancers (Basel)       Date:  2021-11-27       Impact factor: 6.639

Review 6.  Alternaria as an Inducer of Allergic Sensitization.

Authors:  Guadalupe Hernandez-Ramirez; Domingo Barber; Jaime Tome-Amat; Maria Garrido-Arandia; Araceli Diaz-Perales
Journal:  J Fungi (Basel)       Date:  2021-10-07

7.  Endothelin-A Receptor Antagonist Alleviates Allergic Airway Inflammation via the Inhibition of ILC2 Function.

Authors:  Xiaogang Zhang; Ziyang Chen; Shaowen Zuo; Hengbiao Sun; Xinyao Li; Xiao Lu; Zhe Xing; Meiqi Chen; Jingping Liu; Gang Xiao; Yumei He
Journal:  Front Immunol       Date:  2022-02-11       Impact factor: 7.561

8.  RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R.

Authors:  Jana H Badrani; Allyssa N Strohm; Lee Lacasa; Blake Civello; Kellen Cavagnero; Yung-An Haung; Michael Amadeo; Luay H Naji; Sean J Lund; Anthea Leng; Hyojoung Kim; Rachel E Baum; Naseem Khorram; Monalisa Mondal; Grégory Seumois; Julie Pilotte; Peter W Vanderklish; Heather M McGee; Taylor A Doherty
Journal:  Nat Commun       Date:  2022-07-30       Impact factor: 17.694

9.  ILC2s: Are they what we think they are?

Authors:  Kellen J Cavagnero; Taylor A Doherty
Journal:  J Allergy Clin Immunol       Date:  2020-06-12       Impact factor: 10.793

Review 10.  Functional Contribution and Targeted Migration of Group-2 Innate Lymphoid Cells in Inflammatory Lung Diseases: Being at the Right Place at the Right Time.

Authors:  Stefan Wirtz; Anja Schulz-Kuhnt; Markus F Neurath; Imke Atreya
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.